Table 1

Survival and characteristics of cancer

Tumor site

European average 5-year survival [63,64]

Tumor category (WHO)a

Risk of relapseb[53,54,59-61]

Recurrence rate after transplantation [53,54,59-61]


Pancreas

5.7%

5

-

-

Liver

9.1%

2

-

-

Esophagus

11.1%

3

-

-

Lung

12.0%

3

-

-

Gallbladder and biliary tract

14.4%

5

-

-

Brain

19.7%

-

-

Stomach

24.5%

3

-

-

Multiple myeloma

35.1%

+++

>25%

Ovary and uterine adnexa

36.5%

2

-

-

Head and neck

39.5%

3

-

-

All leukemias

42.4%

1 and 3

-

-

NHL

51.5%

1

+

Up to 10%

Colorectal

54.0%

2

++

11%-25%

Bone and cartilage

55.5%

3

+++

>25%

Kidney

58.0%

+++

>25%

Soft tissue sarcoma

59.5%

2

+++

>25%

Cervix uteri

62.6%

3

+

Up to 10%

Bladder

72.4%

3

+++

>25%

Larynx

62.8%

4

Corpus uteri

76.2%

3

++

11%-25%

Prostate

76.4%

3

++

11%-25%

Breast

79.4%

2

++

11%-25%

Hodgkin

80.1%

1

+

Up to 10%

Melanoma of skin

82.6%

5

+++

>25%

Thyroid

82.9%

5

+

Up to 10%

Testis

89.5%

1

+

Up to 10%


aCategory 1: These tumors are characterized by their principal curability; that is, the use of single or combination drug therapy will result in the cure of at least some patients. Category 2: For these cancers, the survival is prolonged when adjuvant chemotherapy is used with surgery or radiotherapy in the early stages. Category 3: These are neoplasms, for which there is evidence that the use of a single drug or combination of drugs will cause tumor shrinkage and possibly improve quality of life; survival may be prolonged but this may be of short duration. Category 4: The local control of these malignancies may be improved by the use of chemotherapy before, during, or after surgery or radiotherapy. Category 5: These are tumors for which there are currently no effective drugs. bRisk of relapse is categorized as low (+), intermediate (++), or high (+++). NHL, non-Hodgkin lymphoma; WHO, World Health Organization.

Elandt and Aletaha Arthritis Research & Therapy 2011 13:223   doi:10.1186/ar3352